Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Surgery

The new gold-standard — medical gastric bypass

Nature Reviews Endocrinology volume 14, pages 257–258 (2018)Cite this article

Subjects

A recent randomized controlled clinical trial with 5-year follow-up demonstrates the impressive effectiveness of the combination of metabolic surgery with medical therapies and shifts the paradigm in the care of patients with obesity and type 2 diabetes mellitus.

Refers to Ikramuddin, S. et al. Lifestyle intervention and medical management with versus without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study. JAMA 319, 266–278 (2018) | Reges, O. et al. Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy versus usual care obesity management with all-cause mortality. JAMA 319, 279–290 (2018)

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Ikramuddin, S. et al. Lifestyle intervention and medical management with versus without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study. JAMA 319, 266–278 (2018).

    Article  Google Scholar 

  2. Reges, O. et al. Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy versus usual care obesity management with all-cause mortality. JAMA 319, 279–290 (2018).

    Article  Google Scholar 

  3. Sjostrom, L. et al. Bariatric surgery and long-term cardiovascular events. JAMA 307, 56–65 (2012).

    Article  Google Scholar 

  4. Lean, M. E. J. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551 (2018).

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Academic Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, UK

    Alexander D. Miras & Carel W. le Roux

  2. Diabetes Complications Research Centre, Conway Institute, University College, Dublin, Ireland

    Carel W. le Roux

Authors
  1. Alexander D. Miras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carel W. le Roux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carel W. le Roux.

Ethics declarations

Competing interests

C.W.l.R is on the advisory boards for Johnson & Johnson, Fractyl, GI, Dynamics, NovoNordisk and Herbalife. A.M has received research grants or honoraria from Fractyl, Johnson & Johnson, NovoNordisk, Astrazeneca and Boehringer Ingelheim

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Miras, A., le Roux, C. The new gold-standard — medical gastric bypass. Nat Rev Endocrinol 14, 257–258 (2018). https://doi.org/10.1038/nrendo.2018.28

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2018.28

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing